Middle East & Africa Direct-to-Consumer Laboratory Testing Market: Introduction

 

According to the report, the direct-to-consumer laboratory testing market in MEA was valued at US$ 124.40 Mn in 2020 and is projected to expand at a CAGR of 18.3% from 2021 to 2031. Direct-to-consumer laboratory testing, also known as direct access testing, allows patients to order tests directly from a lab without having to go through a healthcare professional. These test results can be used to track a current health condition, diagnose a previously undiagnosed medical condition, or provide information on personal health traits. In line with the rise in demand for quick, affordable, and accurate tests, several companies have considered offering actionable recommendations to complement the test results. This approach induces the customer to seek personalized services and maximizes customer satisfaction. This is anticipated to propel the market during the forecast period from 2021 to 2031.

 

Rest of MEA held major share of the direct-to-consumer laboratory testing market in MEA in 2020, due to increase in government regulations, technological advancements, rise in awareness among people, and surge in the geriatric population.

 

Request a Sample of Direct-to-Consumer Laboratory Testing Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=83925

 

Genetic Testing Dominated Middle East & Africa Direct-to-Consumer Laboratory Testing Market

 

In terms of test type, the direct-to-consumer laboratory testing market in MEA has been classified into genetic testing, disease risk assessment testing, CBC, chronic disease testing, COVID-19 testing, TSH testing, and others. The genetic testing segment has been split into nutrigenetics test, celiac disease test, sports & physical activity testing, men's health tests, women's health tests, pregnancy & prenatal screening, general health testing, and others. The nutrigenetics test sub-segment has been segregated into weight control, lactose intolerance, and others. The disease risk assessment testing segment has been classified into sexual health tests, cancer predisposition tests, and others. The sexual health tests sub-segment has been split into HIV, chlamydia, and others. The chronic disease testing segment has been split into diabetes testing, hypertension, and others. The genetic testing segment dominated the direct-to-consumer laboratory testing market in MEA in 2020, and the trend is projected to continue during the forecast period.

 

Enquiry before Buying Direct-to-Consumer Laboratory Testing Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=83925

 

Saliva Sample Type Held Major Market Share

 

Based on sample type, the direct-to-consumer laboratory testing market in MEA has been categorized into blood, saliva, urine, and others. The saliva segment held major share of the direct-to-consumer laboratory testing market in MEA in 2020.

 

Diagnostic Centers Emerge as Key Providers of Direct-to-Consumer Laboratory Tests

 

In terms of provider, the direct-to-consumer laboratory testing market in MEA has been divided into hospitals, clinics, specialty labs, and diagnostic centers. The diagnostic centers segment dominated the direct-to-consumer laboratory testing market in MEA during the forecast period.

 

Buy now Direct-to-Consumer Laboratory Testing Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=83925&ltype=S

 

Rest of MEA to Lead Market

 

In terms of country/sub-region, the direct-to-consumer laboratory testing market in MEA has been segmented into GCC Countries, South Africa, and Rest of MEA. Rest of MEA is anticipated to account for a leading share of the direct-to-consumer laboratory testing market in MEA during the forecast period.

 

Growth Strategies of Key Players

 

Key players operating in the direct-to-consumer laboratory testing market in MEA are 23andMe, Inc., Ancestry, CircleDNA, Eurofins Scientific, Family Tree DNA (Gene by Gene), Laboratory Corporation of America Holdings, Living DNA Ltd., Medichecks.com Ltd., MyHeritage Ltd., MyMedLab, Inc., and Quest Diagnostics Incorporated. The direct-to-consumer laboratory testing market in MEA is consolidated with the presence of international and local players.

 

More Trending Reports by Transparency Market Research:

 

https://www.prnewswire.co.uk/news-releases/continuous-r-amp-d-to-expand-therapeutic-use-of-platelet-rich-plasma-prp-in-regenerative-therapies-offer-profitable-opportunities-to-platelet-rich-plasma-market-players-global-market-valuation-to-reach-us-811-34-mn-by-2030-tmr-study-825481498.html

 

https://www.prnewswire.com/news-releases/increase-in-demand-for-new-therapies-for-effective-management-to-drive-global-menopausal-hot-flashes-treatment-market-says-tmr-301378552.html

 

https://www.prnewswire.com/news-releases/plant-based-vaccines-market-is-expected-to-reach-us-2-34-billion-by-2031-end-emergence-of-numerous-infectious-diseases-to-fuel-growth-of-the-market-says-tmr-301385503.html

 

About Us

 

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

 

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

 

Contact

 

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com